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Background: Evolution of splice sites is a well-known phenomenon that results in transcript diversity during
human evolution. Many novel splice sites are derived from repetitive elements and may not contribute to protein
products. Here, we analyzed annotated human protein-coding exons and identified human-specific splice sites that
arose after the human-chimpanzee divergence.
Results: We analyzed multiple alignments of the annotated human protein-coding exons and their respective
orthologous mammalian genome sequences to identify 85 novel splice sites (50 splice acceptors and 35 donors) in
the human genome. The novel protein-coding exons, which are expressed either constitutively or alternatively,
produce novel protein isoforms by insertion, deletion, or frameshift. We found three cases in which the
human-specific isoform conferred novel molecular function in the human cells: the human-specific IMUP protein
isoform induces apoptosis of the trophoblast and is implicated in pre-eclampsia; the intronization of a part of
SMOX gene exon produces inactive spermine oxidase; the human-specific NUB1 isoform shows reduced interaction
with ubiquitin-like proteins, possibly affecting ubiquitin pathways.
Conclusions: Although the generation of novel protein isoforms does not equate to adaptive evolution,
we propose that these cases are useful candidates for a molecular functional study to identify proteomic
changes that might bring about novel phenotypes during human evolution.
Keywords: Splice site, Human genome, Protein variant, Molecular evolutionBackground
Humans have many unique traits compared with those
of other primates that must be derived from genetic
changes acquired during human evolution [1]. These
genetic modifications include accelerated amino acid
substitutions [2,3], de novo origin of protein-coding
genes from non-coding sequences [4], formation of
novel transcript variants by DNA insertion [5], and in-
activation of long-established genes [6,7].
The generation of novel alternative splice sites plays a
role in the evolution of gene structure [8,9]. Alternative
usage of splice sites often results in insertion or deletion
of amino acids and/or frameshift in proteins. Generation
of novel splice sites or activation of cryptic splice sites in* Correspondence: hahny@cau.ac.kr
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reproduction in any medium, provided the ortransposable elements such as Alu repeats is rather com-
mon in human genes [10-13]. These sites are often alter-
natively spliced, as the novel Alu splice sites are
generally weak donors or acceptors and/or the insertion
of Alu-derived fragments into the coding region of genes
generally results in disruption of the host proteins
[14,15]. There are reports on novel exons originating
from non-coding intronic sequences in some organisms
such as rodents and humans [16,17]. However, these are
not species-specific but have been originated during
rodent and primate evolution, respectively; the novel
“human” exons reported by Zhang and Chasin [17]
originated before the human-chimpanzee divergence.
Although many reports are available on novel exons
originating during human evolution, most of them have
no evidence of protein-coding capability or are not
human-specific. In this study, we hypothesized that nu-
cleotide changes in the human genome after the human-al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.biomedcentral.com/1471-2105/13/299chimpanzee divergence may have generated novel splice
sites and produced novel protein-coding exons. To find
such cases, we analyzed annotated human protein cod-
ing exons and their orthologous genomic sequences of
other primates including chimpanzee and some non-
primate mammals. We examined possible changes in the
proteins caused by the formation of novel splice sites.
Results and discussion
Human-specific splice sites
We analyzed multiple alignments of human protein-
coding exons and their respective orthologous sequences
from various primate and mammalian genomes. We
identified 50 canonical splice acceptors (AG) and 35 ca-
nonical splice donors (GT) that had newly arisen in the
human genome after the human-chimpanzee divergence.
Lists of the novel splice acceptors and donors reported
in this study are presented in Additional file 1: Table S1
and in Additional file 2: Table S2, respectively.
In the present study, we aimed to collect highly plaus-
ible cases for generation of novel protein-coding exons
induced by human-specific splice sites. To achieve this
goal, we used annotated protein-coding exons as the ini-
tial data set, excluding exons without annotated coding
regions such as alternative exons that were obtained
from expressed sequence tag (EST) data analysis. We
also employed highly stringent filtering conditions for
subsequent analyses. For example, we discarded exons
that were supported by only a single transcript record,
because these exons are likely to be derived from noisy
splicing events [18]. We also excluded exons that were
derived from repetitive elements, although many novel
exons were reported to be derived from repetitive ele-
ments such as Alu or L1 [5,10-13]. Repetitive elements
are frequently exapted as coding exons during evolution
[19]; however, the vast majority of repeats that appeared
within the coding region of mRNAs cause a frameshift
or a premature termination codon [15]. Therefore, we
only focused on novel coding exons of which their origin
was from a non-repetitive genomic region.
In this study, we only collected canonical splice sites
(GT-AG) although there are many exons flanked by
non-canonical minor splice sites such as GC-AG or
AT-AC [18]. In the early phase of this study, we col-
lected all the human splice junction sequences that
were different from the chimpanzee sequences as can-
didates for human-specific splice sites. We found that
the most of non-canonical human splice sites were not
one of known minor splice sites but random sequences.
We assumed this was due to intrinsic errors in the input
data such as incomplete genome sequence, incorrect
alignment, and non-orthologous alignment. Because we
aimed to collect highly accurate cases, we only consid-
ered canonical splice sites.In all the cases except one, the human-specific splice
sites reported in this study were associated with genes
conserved in mammals. Only one gene (C14orf182)
appeared to be a de novo protein-coding gene derived
from a non-coding sequence. Out of 85 derived human-
specific exons, 42 were annotated as a part of a RefSeq
transcript. Utilization of novel splice sites results in vari-
ous modifications such as splice site shift of ancestral
exons, generation of novel exons (exonization) or intro-
nization of exonic segments. We classified the protein
modification types into 19 categories, which are pre-
sented in Figure 1. The detailed information on represen-
tative cases is shown in Figure 2 and Additional file 3:
Figures S1–S9. Multiple sequence alignments of all the
novel splice sites and associated exons are presented in
Additional file 4: Table S3 (splice acceptor sites) and in
Additional file 5: Table S4 (splice donor sites).
In 18 cases, the human-specific splice sites caused a
frameshift compared with the ancestral open reading
frame. A frameshift mutation often results in premature
termination codon and induces nonsense-mediated
mRNA decay (NMD) [20]. Generally, a stop codon
which is situated at 50–55 nucleotides upstream of the
last exon-exon junction can induce NMD. We looked at
the stop codon position of the 18 human-specific tran-
scripts and found that in all but one case the stop codon
was in the last exon. In one case, the IMUP gene tran-
script variant, the stop codon is in an internal exon.
However, it is very close to the last exon-exon junction
(2 nucleotides upstream) and would not trigger NMD
(see Figure 3A). Therefore, none of the human-specific
transcripts in this study is susceptible to NMD, sugges-
ting the human-specific transcripts are stable in the
human cells.
In nine cases, we found a splice site-associated poly-
morphism in the human population, indicating that these
human-specific transcripts are differentially expressed in
human individuals. The frequencies of the derived allele
that generated a human-specific splice site were: PLP1
(dbSNP accession number rs2233697, AG vs GG),
98.804%; TXNDC16 (rs28759013, AG vs AA), 96.350%;
KHK (rs74537742, AG vs GG), 95.256%; IL12RB1
(rs393548, AG vs GG), 80.378%; HOXD1 (rs13390932, GT
vs GC), 75.443%; XRCC4 (rs1805377, AG vs AA),
65.843%; NIPAL2 (rs3735887, GT vs AT), 46.445%; MRE
11A (rs496797, GT vs AT), 46.374%; and STXBP4
(rs11658717, AG vs AA), 20.947%.
Splice site shift and type change
The generation of a novel splice site close to the ances-
tral site of an exon causes a splice site shift that either
lengthens or shortens the affected exon (category codes
A1–A4 and D1–D4; see Figure 1 for details). Fifty-six of



















































































Figure 1 Summary of splice site generation and protein modification. This figure summarizes the categories of transcript structures
modified by the generation of novel splice acceptors (A) and donors (B) in human proteins. The left column shows a summary of the
modification with the category codes A1–D10. The center column shows a schematic of the transcript and coding region structures. Novel splice
sites are marked by asterisks. The ancestral coding regions (black), derived coding regions (grey), alternative coding regions (hatched), and
untranslated regions (white) are represented by boxes with different patterns. The last column “count” shows the number of cases reported in
this study.
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representative examples). In 50 cases, the derived exon
increased or decreased in size without changing the
downstream reading frame.
In 20 cases, the splice site was shifted by three bases,
producing tandem splice sites known as NAGNAG
acceptors and GTNGTN donors [21-23]. Alternative
usage of these splice sites generated single amino acid
insertion and deletion isoforms. We found 16 NAGNAG
acceptors and four GTNGTN donors (see Figure 2A
and Additional file 3: Figures S1 and S2). Usually, theaddition or deletion of a single codon does not affect
protein function. However, when a functionally import-
ant residue is removed or a nonsense codon is destroyed
or added, the result can be substantial and cause dis-
eases in humans [21,24]. There was no premature stop
codon in the cases reported in this study. The TassDB2
(http://www.tassdb.info) is a comprehensive database of
tandem splice sites in human and mouse [25]. Out of 20
tandem splice sites, 18 were recorded in the TassDB2.
However, it is not previously reported that these splice
sites are human-specific.
Human      cccagGCCCTGGATGCTTCCTGCCAGATTCCATCCACCCCAGGGAGGGGTGGCCACCTCTCCATGTCACTCAATAAGgtagg
Chimp      ..............................................................................c...
Orangutan  ........T....CT...............................................................c...
B.
A.DYNC2LI1 (A1) shift; increase; inframe
Human      attagCAGGATCATGAATTAATTGACCCATTTCCGGTACCTCTGGTCATAATTGGAAGTAAATATGATGTTTTTCAGgtaag
Chimp      ....a.......G.....................................................................
Orangutan  ....a.......G.....................A.................................A.............
C. CLK1(D7) exonization; novel start
Human      gtaagATGGCGGCTGGGCGGAGGCCGGCTTCGGCCCTGTGGCCGGAAAGGCGAGGCTCCCCGTTGAGGG-GGGATTTGCTGGGGTTCCAGAATGTGCGTG
Chimp      .....................................................................-...G..........................
Orangutan  .........................C..................................T....G...T...G..........................
Human      AGCCAAGCAGCTGTGGGGAAACGTTGTCTGGAgtaag
Chimp      .....C...........................c...
Orangutan  ...TGC.......A...................c...
Human      tacagGTGCCTTTCATTATCTCAAGCCAGATATCGCgtaagtgaa (161 nt) aatagTTGGTTTCAAATCCTTTTGAACACGTTCGACAAAAGCAGT
Chimp      ....................................a........        .............................................
Orangutan  ....................................a........        .................T...........A...............
Human      GGAGAAGAGGAAGACCTGGAGCAATAA
Chimp      ...........................
Orangutan  ...........................
D.PAX3 (D9) intronization; frameshift
LMAN1L (D5) exonization; inframe
Figure 2 Examples of human-specific protein-coding exons with novel splice sites. In each part, the top panel shows the exonic structures
of the human DYNC2LI1 (A), LMAN1L (B), CLK1 (C), and PAX3 (D) gene transcripts. The transcript isoform with a novel protein-coding exon is
marked by an arrow at the right. A multiple sequence alignment of the orthologous segments from the human, chimpanzee, and orangutan
genomes is shown below each panel (see Additional file 2: Tables S2A and S2B for the alignment of all species examined). The coding regions of
the human-specific exon is in uppercase. The novel splice sites (gt and ag), start codon (ATG), and stop codon (TAA) in humans are highlighted
in black. The conserved ancestral splice sites, stop codon (taa in D), and human cryptic splice sites are highlighted in grey. The underlined
sequence in the human PAX3 (D) gene indicates the intronized region. Dots indicate that the sequences are the same as the human sequence.
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exon 45 of the human DOCK1 gene (see Additional file
3: Figure S9). However, the orthologous mammalian
exon used GC as the splice donor so that the exon
boundaries are conserved in human and mammals.
Thus, the ancestral GC-AG intron had changed to a
canonical GT-AG intron in humans. Although boththe GC-AG and GT-AG splice sites are processed by
the standard U2-type spliceosome, the strength of the
donor site could be affected [26].
Exonization and intronization
In 21 cases, the novel splice sites (six acceptors and 15
donors) arose in the non-coding region resulting in
B. SMOX (A8) intronization; inframe
A. IMUP (C19orf33) (A2) shift; increase; frame shift
C. NUB1 (D3) shift; decrease; inframe
Human      GCCTCAGCCCGCCCCAGAGGCCCTGAGATTGAGCCCCGGGgtgag (148 nt) cgctagGTGTGCTAAAGAGGCAGTACACCAGTTTCTTCCGGCCAG
Chimp      .............................................          ....g..C.....G...............................
Orangutan  .............................................          ....g..C.....G...............................
Human      taaagGAACTGGCCCAAATAAGGAAGGAGGAAAAAGAGAAGAAAAGACGCCGCCTCGAGAACATCAGGTTTCTGAAAGGGATGGGCTACTCCACGCACGC
Chimp      .......................................................G.............................T..............
Orangutan  .....................................................................G..............................
Human      GGCCCAGCAGgtact
Chimp      ...........c...
Orangutan  ...........cg..
Human     cttagGCCTCCAACTTCAGGGGGCTGGGTAAGGGGCGCCGCCTCACTGCCGCACCTCCATCCAGCAAGGACACCACAGCTCTTCCGACTCCAGCAGCAGC
Chimp     ...g.............-.........................................................G........................
Orangutan ...g...T.........-..................A.....................................................T.........
Human     TCCAGCGATTCGGACACGGATGTGAaggta
Chimp     ..............................
Orangutan ........C.....................
Figure 3 Human-specific protein isoforms with reported molecular function. The human-specific coding exons for the IMUP isoform
2 (IMUP-2) (A), SMOX isoforms 2 and 4 (B), and the NUB1 isoform 2 (C) are presented. The transcript isoform with a novel protein-coding exon is
marked by an arrow at the right. The downward arrowhead in the IMUP-2 exon indicates the human-specific insertion of an adenine nucleotide.
The coding region of the human-specific exon is in uppercase. The novel splice sites (gt and ag) and the stop codon (TGA in IMUP-2) in humans
are highlighted in black. The conserved ancestral and human cryptic splice sites are highlighted in grey. The underlined sequence in the human
SMOX (B) gene indicates the intronized region. Dots indicate that the sequences are the same as the human sequence.
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http://www.biomedcentral.com/1471-2105/13/299exonization of intronic segments (categories A5–A9 and
D5–D9; see Figure 1 for details). A cryptic intronic
splice donor for a given novel acceptor or a cryptic ac-
ceptor for a novel donor was activated in the human
genome. The 13 cases generated novel internal exons
that added some additional amino acids (five cases) or
produced alternative C-termini by frameshift (eight
cases) (see Figure 2B and Additional file 3: Figures S5
and S6). In the remaining eight cases, the exons were
associated with cryptic or authentic promoters and pro-
duced alternative N-termini of the proteins (see
Figure 2C and Additional file 3: Figure S7).
Interestingly, in five cases, novel splice acceptors or
donors appeared in the exons, and corresponding cryp-
tic exonic donors or acceptors were accordingly acti-
vated. As a result, part of the exonic sequence wasspliced out as an intron (see Figure 2D and Additional
file 3: Figure S8).
Novel molecular function of human-specific protein
isoforms
We performed a literature review to find reported
molecular functions of human-specific protein iso-
forms produced by human-specific splice sites. We
found three cases (IMUP, SMOX, and NUB1) of which
the molecular function of the human-specific protein
isoform has been described.
The human IMUP (also known as C19orf33) gene
encoding immortalization-up-regulated protein produces
two protein isoforms reported as IMUP-1 and IMUP-2,
respectively (http://www.uniprot.org/uniprot/Q9GZP8).
Both isoforms are highly expressed in cancer cells and
localized in the nucleus [27,28]. These two protein
multiz46way alignments
of human coding exons
coding exons with splice site
(556,966 exons)
167 candidates
(84 acceptors and 83 donors)
computational filtering
derived from a repetitive element
85 human specific splice sites
(50 acceptors and 35 donors)
functional analysis
manual inspection
human splice site is non canonical or
 data set without chimpanzee




 multiple copies in human genome
 incorrect chimpanzee sequence
 repeat derived exon
 annotated as non coding RNA
only one mRNA/EST record









Figure 4 Procedure for identifying human-specific splice sites
of annotated human proteins.
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ent C-termini. The IMUP-2 protein (isoform 2 of IMUP)
is a human-specific isoform that is produced by using a
human-specific splice donor site (Figure 3A). IMUP-2
expression is specifically elevated during preterm pre-
eclampsia and under hypoxic conditions, and the IMUP-
2 protein induces apoptosis of the trophoblast [29].
Therefore, production of the IMUP-2 human-specific
isoform may be functionally involved in placental devel-
opment and gynecological diseases such as pre-eclampsia.
This case clearly shows that a human-specific protein
isoform induced by the generation of a novel splice site
sequence plays a role in the human cells and is associated
with a phenotype.
The human SMOX gene encoding spermine oxidase is
implicated in various tumors and diseases in humans
[30-32]. Alternative splicing of the human SMOX gene
transcripts results in the production of six protein iso-
forms (http://www.uniprot.org/uniprot/Q9NWM0). A
part of exon 5 can act as an intron and is spliced out to
produce SMOX protein isoforms 2 and 4 [33]. We found
that this intronization of an internal part of exon 5 was
induced by the generation of a human-specific splice
donor sequence (Figure 3B). This intronization removed
53 amino acids from the ancestral form. Many of these
residues are highly conserved components of the FAD-
binding domain and are essential for catalysis. Therefore,
the deletion caused by the intronization seemed to result
in the production of catalytically inactive spermine
oxidase protein [33,34]. The human-specific SMOX
protein isoform 4 has been localized in the nucleus
[34]. Although the human-specific SMOX isoforms
are inactive as oxidases, it is possible that they could
confer other molecular functions in the human cell in
general, or that production of non-functional isoform
could decrease the cellular concentration of active
spermine oxidase and affect spermine catabolism.
The human NUB1 gene encodes two isoforms of a
negative regulator of ubiquitin-like proteins 1 (originally
known as NEDD8 ultimate buster-1) [35]. Isoforms 1
(also known as NUB1L for larger variant) and 2 are
615-aa and 601-aa long, respectively. We identified that
the 601-aa-long isoform 2 was produced using a human-
specific splice donor site (Figure 3C). The NUB1 protein
interacts with ubiquitin-like proteins such as NEDD8
and FAT10 and accelerates their degradation [36-38].
Downregulation of NEDD8 by NUB1 leads to decreased
p53 modification, resulting in cytoplasmic localization
and inhibition of p53 transcriptional activity [39]. The
generation of the novel splice donor site within exon 12
resulted in shortening of the exon and removal of 14
amino acids from the ancestral form. Human-specific
isoform 2 has been detected almost equally in all exam-
ined tissues and shows a higher expression level than thatof ancestral isoform 1, which is not equally detected in
tissues examined [35]. The 14-aa deletion removes one
of the ubiquitin associated domains, probably resulting
in weakening of the interaction between NUB1 and
ubiquitin-like proteins. Actually, isoform 2 is less efficient
in promoting degradation of NEDD8 [40]. Therefore, pro-
duction of the human-specific NUB1 isoform 2 may affect
the ubiquitin pathway in human cells.
Conclusions
We identified 85 cases of annotated human protein-
coding exons with evidence of substantial expression
that had been generated by acquisition of a novel splice
site in the human genome. The novel protein-coding
exons were expressed either constitutively or alterna-
tively. We found three cases in which the human-
specific isoform conferred novel molecular function. We
propose that the generation of novel splice sites contri-
butes to the evolution of the human genome and the
variety of protein isoforms that may furnish novel func-
tional proteins and novel phenotypes.
Methods
Collection of human-specific splice site candidates
The overall procedure we employed in this study is pre-
sented in Figure 4. We downloaded the multiple alignment
data of the human protein-coding exon sequences and
their mammalian orthologous genome sequences from the
University of California Santa Cruz (UCSC) Genome
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coding regions were defined in the “knownGene” track,
and the multiple sequence alignments of the coding
regions were derived from the “multiz46way” alignment
data. We extracted the protein-coding exon sequences,
padded by 2 bp at both ends, from the respective genome
assemblies. The genome assemblies analyzed in the present
study included 10 primates and three other representative
non-primate mammals: human (hg19), chimpanzee
(panTro2), gorilla (gorGor1), orangutan (ponAbe2), rhe-
sus macaque (rheMac2), baboon (papHam1), marmoset
(calJac1), tarsier (tarSyr1), bushbaby, also known as galago
(otoGar1), mouse lemur (micMur1), mouse (mm9), dog
(canFam2), and cow (bosTau4).
We discarded splice sites derived from repetitive
elements which were marked in lowercase in the repeat-
masked genome sequences. When a human protein-
coding exon has a canonical splice sequence (GT as the
donor and AG as the acceptor), but the chimpanzee
and other primates have a different sequence (other than
GT or AG), we considered it to be a case of human-
specific acquisition of a novel splice site after the human-
chimpanzee divergence. We collected 167 human-specific
splice site candidates (84 acceptors and 83 donors) by
filtering the multiple alignment data.
Manual inspection of the candidates
We scrutinized each case by visual inspection mainly based
on data available in the UCSC Genome Browser. We dis-
carded cases showing one of the following conditions: the
novel human exon was derived from a repeat sequence (the
exon overlaps a repetitive element in the “RepeatMasker”
track); the orthologous chimpanzee genomic segment had
a sequencing error (the “Quality Score” track of the chim-
panzee genome was reviewed); the orthology relationship
of the gene was ambiguous due to the presence of highly
similar paralogous copies in the human genome (BLAT
was used to map the sequence to the human genome);
the corresponding human transcript was annotated as a
non-coding RNA (RefSeq record was reviewed); or the
human transcript was not supported by two or more tran-
script records in the database (human mRNA and EST
tracks were analyzed). As a result, we identified 50 splice
acceptors (AG) and 35 splice donors (GT) that were spe-
cific to humans.
We compared the structures of the derived human
exons and corresponding ancestral mammalian genome
sequences to classify the protein modification types. We
examined human mRNA and EST tracks of the UCSC
Genome Browser to determine whether a novel splice
site is used alternatively or constitutively. For the human
simple nucleotide polymorphism (SNP), we analyzed the
“Common SNPs(135)” or “Common SNPs(132)” track of
the UCSC Genome Browser. We referred to UniProtdatabase (http://www.uniprot.org) for characterized mo-
lecular function of the human-specific protein isoforms.
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